Germany - ยง Section 130a (8) SGB V enables the health insurance funds (KK) and pharmaceutical companies
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 10 November 2025
- Opportunity publication date
- 23 May 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
ยง Section 130a (8) SGB V enables health insurance funds (KK) and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory health insurance funds. GWQ acts as a company for efficiency and quality at SHI funds in accordance with Section 130a (8) sentence 5 SGBV for its shareholder and customer SHI funds. With regard to the relevant statutory provisions on the award of public contracts, GWQ ServicePlus AG carries out a regular process of formal award procedures for active pharmaceutical ingredients in accordance with the regulations of Part 4 of the GWB. GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies until new drug discount agreements come into force. The contract start date is 01.07.2024.
- Opportunity closing date
- 10 November 2025
- Value of contract
- to be confirmed
About the buyer
- Address
- GWQ ServicePlus AG
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.